Canada Is Being Groomed To Be A Global Example For Medical Reefer

excel named ranges trick

About a dozen producers of the drug will find themselves in the spotlight this year as they consider going public or prepare to so through share sales or reverse takeovers to capitalize on recent regulatory changes, investment bankers said. The Canadian companies are in a race to raise money to build facilities, attract patients and grab shares in a market projected to grow to C$1.3 billion ($1.20 billion) in the next 10 years. Despite facing considerable risks, they have the advantage of being in one of the few countries where medical marijuana is legal nationwide and where licensed operators can mass-produce it.

In the United States, the drug remains illegal at the federal level. Some 20 U.S. states have legalized medical marijuana, but investors worry about the prospect, however remote, that the federal government may strike down those laws. Although the U.S. market is home to companies including Medical Marijuana Inc and Cannabis Science Inc , their northern counterparts are likely to benefit from greater legitimacy and legal clarity.

To read more, visit

Posted in: Investing

Comments are closed.